| Name | Title | Contact Details |
|---|
Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.
Pioneering skin cancer tools for you and your family. DermaSensor is designing an affordable handheld sensor device that will let you scan your skin for irregular lesions in seconds.
Catholic Health Services is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Siskin Hospital was founded in 1989 as the first freestanding, not-for-profit rehabilitation hospital in Tennessee built specifically for rehabilitation patients. Currently, Siskin Hospital remains as the only not-for-profit rehabilitation hospital in Tennessee, offering an all-inclusive campus, as well as off-campus locations, dedicated to meeting a wide variety of rehabilitation needs. Siskin Hospital offers all private patient rooms and has specialized Inpatient treatment programs in brain injury, amputation, stroke, spinal cord injury, orthopedics, neurological disorders, and major multiple trauma, among other illnesses and disorders.
Relievant Medsystems, Inc., a privately held medical device company pioneering the INTRACEPT therapy of nerve ablation within vertebral bodies for the treatment of chronic low back pain (CLBP). The INTRACEPT Intraosseous Nerve Ablation System is a patent-protected, minimally invasive, implant-free therapy that utilizes radiofrequency energy delivered into the vertebral body of the spine to ablate the Basivertebral Nerve (BVN). This nerve, characterized in peer-reviewed literature reporting studies of pain signal transmission and in preclinical and clinical evaluations, is a significant contributor in the transduction of pain arising from degeneration of the vertebral bodies associated with CLBP. The INTRACEPT Intraosseous Nerve Ablation System leverages proprietary instruments and methods to disable this nerve.